Dr. Shahrad Hakimian, MD

Dr. Hakimian practices at Cedars-Sinai Medical Care Foundation in Beverly Hills, California.

Dr. Hakimian's NPI, 1245625326, was assigned on April 6, 2015. Dr. Hakimian graduated from Tufts University School Of Medicine in 2015. Dr. Hakimian holds California license A171473.

Dr. Hakimian's primary practice is Cedars-Sinai Medical Care Foundation, at 8536 Wilshire Blvd, Beverly Hills, CA 90211 in Los Angeles County. The practice phone is (310) 385-3200.

Dr. Hakimian's primary practice is Cedars-Sinai Medical Care Foundation in Beverly Hills, California. Dr. Hakimian is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Hakimian to 2 more hospitals and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hakimian practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Hakimian's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Hakimian is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Hakimian's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists acid reflux, colonoscopy, gastroenteritis, gastrointestinal bleeding, hepatitis c, intestinal or bowel obstruction, irritable bowel syndrome (IBS) and upper GI endoscopy among the conditions Dr. Hakimian treats.

CMS data shows 546 Medicare services from Dr. Hakimian across 11 procedure codes in 2024, for 321 Medicare patients. Medicare paid $61,430 for them.

CMS counts 321 Medicare patients who saw Dr. Hakimian in 2024. The largest group is 65 to 74, with 166 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 45% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hakimian's median patient age at 52, with 52% women.

In 2024, Dr. Hakimian wrote 371 Medicare Part D claims for 164 patients. 73% of them were for generic drugs. CMS names the drug for 268 of them, across 7 drugs with 11 or more claims each, at $68,341 in total drug cost. In 2023, CMS named 245 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Hakimian for performance year 2024, reported as part of a group. Dr. Hakimian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hakimian as offering telehealth. CMS counts 58 procedures of colonoscopy by Dr. Hakimian, more than 67% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Hakimian, published from 2013 to 2025. Dr. Hakimian's most frequent co-authors are Richard Aaron Hodin, MD, Omeed Moaven, MD and Madhury Ray, MD.

CMS Open Payments shows 10 general payments to Dr. Hakimian from 6 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $177.

Dr. Hakimian graduated from Tufts University School Of Medicine in 2015.

Dr. Hakimian is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.